Patent details

EP1635799 Title: Pharmaceutical formulations of amyloid inhibiting compounds.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1635799
WO Application Number:
IB2004002381
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP04744039.1
WO Publication Number:
WO2004112762
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
21/06/2004
Grant date:
05/08/2009
EP Publication Date:
05/08/2009
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/08/2009
EP B1 Publication Date:
05/08/2009
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
20/06/2024
Lapsed By Expiration Date:
21/06/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/08/2009
 
 

 

Name:
BELLUS Health (International) Limited
Address:
Parc Scientifique sur le site de l'Ecole Polytechnique Fédérale de Lausanne à Ecublens, 1015, Lausanne, Switzerland (CH)

Domicile Holder

Name:
dr. ir. G.J.C. Verdijck c.s.
From:
05/08/2009
Address:
Octrooibureau Arnold & Siedsma p/a Postbus 18558, 2502 EN, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
Audley LEGORE
Address:
H7W 1N8, Laval, Quebec, Canada (CA)

2

Name:
Denis GARCEAU
Address:
H9N 4N1, Kirkland, Quebec, Canada (CA)

Priority

1

Priority Patent Number:
871549
Priority Date:
18/06/2004
Priority Country:
United States of America (US)

2

Priority Patent Number:
512116 P
Priority Date:
17/10/2003
Priority Country:
United States of America (US)

3

Priority Patent Number:
480984 P
Priority Date:
23/06/2003
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/00;
IPC or IDT classification:
A61K 9/22; A61K 9/32; A61K 31/185; A61P 3/10; A61P 25/00; A61P 25/28; A61P 31/04; A61P 31/12; A61P 43/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
26/24
Publication date:
26/06/2024
Description:
Lapse or annulment

2

Bulletin Heading:
EP4
Journal edition number:
2010/01
Publication date:
04/01/2010
Description:
European patents granted in amended form for the Netherlands

3

Bulletin Heading:
EP2
Journal edition number:
2009/10
Publication date:
01/10/2009
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200932
Publication date:
05/08/2009
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
20/06/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
23/10/2009 Claims Translated claims 2 PDF /9/3/0/4/4/0504744039/docs/ep04744039.1_0_claims20091023.pdf
23/10/2009 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/3/0/4/4/0504744039/docs/ep04744039.1_2_incomingcorrespondencepaper20091023.pdf
23/10/2009 Outgoing Correspondence Outgoing Letter 1 PDF /9/3/0/4/4/0504744039/docs/ep04744039.1_4_outgoingcorrespondence20091023.pdf
28/07/2009 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /9/3/0/4/4/0504744039/docs/ep04744039.1_1_incomingcorrespondencepaper20090728.pdf
28/07/2009 Outgoing Correspondence Outgoing Letter 1 PDF /9/3/0/4/4/0504744039/docs/ep04744039.1_3_outgoingcorrespondence20090728.pdf